Viewing StudyNCT04248569



Ignite Creation Date: 2024-05-06 @ 2:12 PM
Last Modification Date: 2024-10-26 @ 1:27 PM
Study NCT ID: NCT04248569
Status: RECRUITING
Last Update Posted: 2024-06-07
First Post: 2020-01-28

Brief Title: DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma
Sponsor:
Organization: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins